×
0.0423728813559322 0.0423728813559322 0.0677966101694916 0.0338983050847458 0.0169491525423729 0.0423728813559322 0.0254237288135593 0.0254237288135593
Stockreport

U.S. FDA Approves Cost Recovery for PLX-PAD under Expanded Access Program in the Treatment of Critical Limb Ischemia

PLURISTEM THERAPEUTIC (PSTI)  More Company Research Source: GlobeNewswire
Last pluristem therapeutic earnings: 11/7 04:22 pm Check Earnings Report
US:NASDAQ Investor Relations: pluristem.com
PDF Pluristem enters into agreement with WideTrial Inc. to conduct the programWideTrial will purchase PLX-PAD cell products from PluristemProgram makes investigational treatment available to CLI patients who are unsuitable for inclusion in the Company’s ongoing multinational Phase 3 clinical study Allows for collection of real-world data concurrent with the Phase 3 study HAIFA, Israel and SAN FRANCISCO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, and WideTrial Inc., a privately-held third-party sponsor of authorized Expanded Access Programs (EAPs), today announced that the parties have entered into agreement to initiate an FDA-cleared EAP for Pluristem’s cell therapy product, PLX-PAD, for the treatment of critical limb ischemia (CLI). The parties further announced that the FDA has authorized WideTrial to charge payment for the PLX-PAD EAP treatment [Read more]

IMPACT SNAPSHOT EVENT TIME: PSTI
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
PSTI alerts
from News Quantified
Opt-in for
PSTI alerts

from News Quantified
Opt-in for
PSTI alerts

from News Quantified